1 ื“ืงื•ืช ืงืจื™ืื”
๐ŸŽฎ ื˜ื™ืคื•ืœ ื‘-ADHD ื“ืจืš ืžืฉื—ืง ื•ื™ื“ืื• ืจืืฉื•ืŸ ืžืกื•ื’ื• ืฉืื•ืฉืจ ืขืœ ื™ื“ื™ ื”-FDA

๐Ÿง  Akili Interactive: ื›ืฉืžืฉื—ืงื™ื ืžืจืคืื™ื

ื—ื‘ืจืช Akili Interactive, ืžื”ืžื•ื‘ื™ืœื•ืช ื‘ืชื—ื•ื ื‘ืจื™ืื•ืช ื“ื™ื’ื™ื˜ืœื™ืช ื•ื”ื•ืคื™ืขื” ืžืกืคืจ ืคืขืžื™ื ื‘ืชืขืจื•ื›ืช CESยฎ, ื™ืฆืจื” ืืช EndeavorRx โ€“ ืžืฉื—ืง ืฉืคื•ืชื— ื‘ืžื™ื•ื—ื“ ืขื‘ื•ืจ ื™ืœื“ื™ื ืขื ADHD.

ื”ืžืฉื—ืง ื ื‘ื ื” ืขืœ ื’ื‘ื™ ืืœื’ื•ืจื™ืชืžื™ื ืžืชืงื“ืžื™ื ืฉื ื•ืขื“ื• ืœืฉืคืจ ืชืคืงื•ื“ื™ื ื ื•ื™ืจื•ืœื•ื’ื™ื™ื ืฉืœ ืงืฉื‘, ืฉืœื™ื˜ื” ื‘ื“ื—ืคื™ื, ื–ื™ื›ืจื•ืŸ, ื ื™ื•ื•ื˜ ืžืจื—ื‘ื™ ื•ืขื•ื“.



๐ŸŽฏ ืื™ืš ื–ื” ืขื•ื‘ื“?

ื‘ืœื‘ ื”ื˜ื›ื ื•ืœื•ื’ื™ื” ืฉืœ Akili ื ืžืฆืืช ืžืขืจื›ืช ื™ื™ื—ื•ื“ื™ืช ื‘ืฉื Selective Stimulus Management Engine (SSME) โ€“ ืžื ื•ืข ื‘ื™ื ื” ืžืœืื›ื•ืชื™ืช ืฉืžืกืชื ื›ืจืŸ ืขื ืคืขื•ืœืช ื”ืžื•ื— ื•ืžืชืื™ื ืืช ืจืžืช ื”ืงื•ืฉื™ ืฉืœ ื”ืžืฉื—ืง ื‘ื–ืžืŸ ืืžืช, ืœืคื™ ื”ื‘ื™ืฆื•ืขื™ื ืฉืœ ื”ื™ืœื“.ื”ืžื˜ืจื”: ืœืืžืŸ ืืช ื”ืžื•ื— ืœื”ืชืžื•ื“ื“ ืขื ื’ื™ืจื•ื™ื™ื ืžืฉืชื ื™ื, ืœื‘ืฆืข ืจื™ื‘ื•ื™ ืžืฉื™ืžื•ืช, ืœืฉืคืจ ืืช ื”ืจื™ื›ื•ื– ื•ืœื”ืคื—ื™ืช ืžื•ืกื—ื•ืช โ€“ ื›ืœ ื–ืืช ืชื•ืš ื—ื•ื•ื™ื” ื›ื™ืคื™ืช ื•ืžืฉื—ืงื™ืช.



๐Ÿ’Š ืืœื˜ืจื ื˜ื™ื‘ื” ืœืชืจื•ืคื•ืช โ€“ ืžืฉื—ืง ื‘ืžืงื•ื ื›ื“ื•ืจ

ื‘ืขื‘ืจ, ื”ืคืชืจื•ืŸ ื”ืงืœืืกื™ ืœื™ืœื“ื™ื ืขื ADHD ื›ืœืœ ืชืจื•ืคื•ืช ืขื ืชื•ืคืขื•ืช ืœื•ื•ืื™ ืœื ื ืขื™ืžื•ืช.ื›ื™ื•ื, EndeavorRx ืžืฆื™ืข ื˜ื™ืคื•ืœ ืœื ืคื•ืœืฉื ื™, ืœืœื ืชื•ืคืขื•ืช ืœื•ื•ืื™, ื›ื—ืœื•ืคื” ืื• ืฉื™ืœื•ื‘ ืœื˜ื™ืคื•ืœื™ื ื”ืชืจื•ืคืชื™ื™ื ื”ืžืกื•ืจืชื™ื™ื.ื‘ืžื—ืงืจื™ื ืงืœื™ื ื™ื™ื ื ืžืฆื ื›ื™ ืœืื—ืจ ืฉื™ืžื•ืฉ ื™ื•ืžื™ ืฉืœ 25 ื“ืงื•ืช, ื‘ืžืฉืš 4 ืฉื‘ื•ืขื•ืช โ€“ ื ืจืฉื ืฉื™ืคื•ืจ ืžืฉืžืขื•ืชื™ ื‘ื™ื›ื•ืœื•ืช ื”ืงืฉื‘ ืฉืœ ื”ื™ืœื“ื™ื ื”ืžืฉืชืžืฉื™ื.




๐Ÿ”ฎ ื”ืขืชื™ื“ ื”ื“ื™ื’ื™ื˜ืœื™ ืฉืœ ื”ืจืคื•ืื” ื›ื‘ืจ ื›ืืŸ

ืžื ื›"ืœ Akili, ื“"ืจ ืื“ื™ ืžืจื˜ื•ืฆโ€™ื™, ืžืกื‘ื™ืจ ื›ื™ ืžื“ื•ื‘ืจ ืจืง ื‘ืชื—ื™ืœืชื” ืฉืœ ืžื”ืคื›ื”. ื‘ืฉื ืช 2025, ืชื—ื•ื ื”ืชืจืคื™ื” ื”ื“ื™ื’ื™ื˜ืœื™ืช ืžืžืฉื™ืš ืœืฆืžื•ื— ื‘ืžื”ื™ืจื•ืช โ€“ ื‘ื–ื›ื•ืช ืขืœื•ื™ื•ืช ื˜ื™ืคื•ืœ ื ืžื•ื›ื•ืช ื™ื•ืชืจ, ื ื’ื™ืฉื•ืช ื’ื‘ื•ื”ื”, ื•ื”ื™ื›ื•ืœืช ืœื”ืชืื™ื ื˜ื™ืคื•ืœ ืื™ืฉื™ ืœื›ืœ ืžื˜ื•ืคืœ.ื‘ื›ื ืก CES ื”ืื—ืจื•ืŸ, ืฆื™ื™ืŸ ืžืจื˜ื•ืฆโ€™ื™:

"ื”ื’ื™ืข ื”ื–ืžืŸ ืฉื”ืจืคื•ืื” ืชืœืš ื‘ืขืงื‘ื•ืช ื”ื“ื™ื’ื™ื˜ืœ โ€“ ืœื ื›ืชื—ืœื™ืฃ, ืืœื ื›ื›ืœื™ ืžืจื›ื–ื™ ื‘ืžืขืจื›ืช ื”ื‘ืจื™ืื•ืช ืฉืœ ื”ืžืื” ื”-21."